• Channels
    • All News
    • Premium Content
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Eli Lil­ly joins the grow­ing ranks of Big Phar­ma play­ers man­dat­ing vac­ci­na­tions for most staffers

Last year
Pharma

No­vavax, Fu­ji­film plow ahead on Covid-19 vac­cine pro­duc­tion de­spite OWS set­back

Last year
Coronavirus
Manufacturing

Man­u­fac­tur­ing is­sues hold back dis­tri­b­u­tion of over­dose in­jec­tion; San Diego biotech triples foot­print

Last year
Manufacturing

Two da­ta fal­si­fiers sen­tenced to prison as FDA pledges to crack down on those un­der­min­ing clin­i­cal tri­als

Last year
FDA+

First gener­ic com­pe­ti­tion ar­rives for Pfiz­er's megablock­buster an­ti-smok­ing drug

Last year
Pharma
FDA+

Biden's vi­sion for drug pric­ing re­forms: Medicare ne­go­ti­a­tions, penal­ties for prices ris­ing high­er than in­fla­tion

Last year
Pharma

Sen. Rand Paul re­veals his wife bought Gilead stock in Feb­ru­ary 2020 — 16 months af­ter fil­ing dead­line

Last year
People
Pharma

FDA re­jects Fi­bro­Gen's ane­mia drug, de­mand­ing an ad­di­tion­al clin­i­cal tri­al

Last year
Pharma
FDA+

'The con­sum­mate men­tor': Bill Clin­ton, Jim Wil­son and oth­ers re­flect on Tachi Ya­mada's life and lega­cy

Last year
People
In Focus

Mod­er­na strikes a deal with Cana­da to build an mR­NA man­u­fac­tur­ing cen­ter — and it’s look­ing for more glob­al pacts just like it

Last year
Coronavirus
Manufacturing

Mod­er­na soars in­to the ranks of the world's top phar­ma play­ers, now worth 3 Re­gen­erons

Last year
Bioregnum
Pharma

Gilead joins the move­ment to man­date staff vac­ci­na­tions against Covid-19. And it looks like the rest of the in­dus­try is fol­low­ing

Last year
Pharma

For­mer BAR­DA di­rec­tor set­tles whistle­blow­er case on Trump's mis­man­age­ment of the pan­dem­ic

Last year
People
Coronavirus

ADC ex­perts at Seagen find a $2.6B HER2 gem in Chi­na that they think can go where En­her­tu, Kad­cy­la can't

Last year
Deals
China

Blue­bird forced to halt tri­als af­ter a can­cer-like case, pulls gene ther­a­pies from Eu­rope fol­low­ing pric­ing back­lash — shares slammed

Last year
R&D
Cell/Gene Tx

Philip Mor­ris bags an­oth­er biotech as bid­ding war with Car­lyle over Vec­tura deal heats up

Last year
Deals

Most Fa­vored Na­tions rule for drug pric­ing: Gone, but not for­got­ten

Last year
Pharma

Biotech grieves over Tachi’s pass­ing; $3 tril­lion mi­rage?; Sanofi has a new Pompe drug; and more

Last year
Weekly

Till­man Gern­gross steers a biotech uni­corn to Nas­daq, while an­oth­er com­pa­ny's IPO plans fiz­zle

Last year
Financing

Fed­er­al cir­cuit up­holds Te­va-Glax­o­SmithK­line de­ci­sion, land­ing an­oth­er blow to 'skin­ny' la­bels

Last year
Pharma

Drug pric­ing dis­rup­tor EQRx makes the big leagues with $1.8B SPAC deal and a new CEO at the helm

Last year
Financing
Deals

Courts to de­cide on whether drug­mak­ers have to sup­ply dis­count­ed drugs to un­lim­it­ed con­tract phar­ma­cies

Last year
Pharma

No­vavax shares dive on yet an­oth­er stum­ble in the hunt for an EUA, with FDA de­lay as US paus­es fund­ing

Last year
FDA+

Ox­ford spin­out rais­es $113M in bid to beat Sarep­ta's Ex­ondys 51 in DMD. But will we ever know if any of the drugs work?

Last year
Financing
First page Previous page 116117118119120121122 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Premium Content
  • Don't Miss
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints Company 2023

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
Endpoints News

Log in to your account

e-mail

password

Endpoints News

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

Endpoints News

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

email

Endpoints News

About You

Subscriptions

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET

ENDPOINTS MARKETING RX Tue at 2 PM ET

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET